Literature DB >> 25441433

Complement in kidney disease: core curriculum 2015.

Joshua M Thurman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25441433      PMCID： PMC4272665          DOI： 10.1053/j.ajkd.2014.06.035

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  24 in total

1.  Getting over our Immune-Complex - C5a receptor blockade is the answer.

Authors:  Joshua M Thurman
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

Review 2.  Novel mechanisms and functions of complement.

Authors:  George Hajishengallis; Edimara S Reis; Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Immunol       Date:  2017-11-16       Impact factor: 25.606

Review 3.  Targeting the complement cascade: novel treatments coming down the pike.

Authors:  Joshua M Thurman; Moglie Le Quintrec
Journal:  Kidney Int       Date:  2016-06-18       Impact factor: 10.612

4.  The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma.

Authors:  Margarita Semis; Gabriel B Gugiu; Ellen A Bernstein; Kenneth E Bernstein; Markus Kalkum
Journal:  Anal Chem       Date:  2019-05-07       Impact factor: 6.986

5.  Folic acid-mediated fibrosis is driven by C5a receptor 1-mediated activation of kidney myeloid cells.

Authors:  Ranjit K Sahu; Sandhya Xavier; Daniel Chauss; Luopin Wang; Claude Chew; Ronald Taylor; William B Stallcup; Jennie Z Ma; Majid Kazemian; Behdad Afzali; Jörg Köhl; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-04

6.  Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.

Authors:  Lindsey Goetz; Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Liudmila Kulik; Jelena Klawitter; Erik Stites; Uwe Christians; Johan van der Vlag; Kameswaran Ravichandran; V Michael Holers; Joshua M Thurman
Journal:  Eur J Immunol       Date:  2018-02-22       Impact factor: 5.532

Review 7.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

8.  Complement Deficiencies Result in Surrogate Pathways of Complement Activation in Novel Polygenic Lupus-like Models of Kidney Injury.

Authors:  Sladjana Skopelja-Gardner; Lucrezia Colonna; Payton Hermanson; Xizhang Sun; Lena Tanaka; Joyce Tai; Yenly Nguyen; Jessica M Snyder; Charles E Alpers; Kelly L Hudkins; David J Salant; YuFeng Peng; Keith B Elkon
Journal:  J Immunol       Date:  2020-04-01       Impact factor: 5.422

Review 9.  Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus.

Authors:  Joshua M Thurman; Natalie J Serkova
Journal:  F1000Res       Date:  2015-06-16

Review 10.  Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy.

Authors:  Dorin-Bogdan Borza
Journal:  Front Immunol       Date:  2016-04-25       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.